IL314472A - Product purification methods - Google Patents
Product purification methodsInfo
- Publication number
- IL314472A IL314472A IL314472A IL31447224A IL314472A IL 314472 A IL314472 A IL 314472A IL 314472 A IL314472 A IL 314472A IL 31447224 A IL31447224 A IL 31447224A IL 314472 A IL314472 A IL 314472A
- Authority
- IL
- Israel
- Prior art keywords
- purifying
- methods
- product
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263267810P | 2022-02-10 | 2022-02-10 | |
| PCT/US2023/062322 WO2023154822A2 (en) | 2022-02-10 | 2023-02-09 | Methods of purifying a product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL314472A true IL314472A (en) | 2024-09-01 |
Family
ID=87521638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL314472A IL314472A (en) | 2022-02-10 | 2023-02-09 | Product purification methods |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230250133A1 (enExample) |
| EP (1) | EP4476237A2 (enExample) |
| JP (1) | JP2025505696A (enExample) |
| KR (1) | KR20240142564A (enExample) |
| CN (1) | CN119032099A (enExample) |
| AU (1) | AU2023217074A1 (enExample) |
| CA (1) | CA3251000A1 (enExample) |
| IL (1) | IL314472A (enExample) |
| MX (1) | MX2024009755A (enExample) |
| WO (1) | WO2023154822A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015035342A2 (en) | 2013-09-08 | 2015-03-12 | Oligasis Llc | Factor viii zwitterionic polymer conjugates |
| AU2018250695A1 (en) | 2017-04-14 | 2019-11-07 | Kodiak Sciences Inc. | Complement factor D antagonist antibodies and conjugates thereof |
| US12071476B2 (en) | 2018-03-02 | 2024-08-27 | Kodiak Sciences Inc. | IL-6 antibodies and fusion constructs and conjugates thereof |
| AU2020364071A1 (en) | 2019-10-10 | 2022-05-26 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| WO2025073922A1 (en) * | 2023-10-04 | 2025-04-10 | Sartorius Bia Separations D.O.O. | Enhanced chromatographic separations of components in a mixture by employing chaotropic elution |
| WO2025184423A1 (en) * | 2024-02-29 | 2025-09-04 | Kodiak Sciences Inc. | Cell-surface-targeting-domain-polymer-payload conjugate |
| US20260092109A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf receptor molecules and uses thereof |
| US20260092125A1 (en) * | 2024-09-06 | 2026-04-02 | Eyebiotech Limited | Multivalent fzd4, wnt co-receptor, and vegf binding molecules and uses thereof |
| WO2026075981A1 (en) * | 2024-10-01 | 2026-04-09 | Regeneron Pharmaceuticals, Inc. | Methods of analyzing heterodimeric proteins |
| CN119524125A (zh) * | 2024-11-28 | 2025-02-28 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液的生产方法及欧莫扑拜单抗原液 |
| CN119454939A (zh) * | 2024-11-28 | 2025-02-18 | 北海康成(苏州)生物制药有限公司 | 一种欧莫扑拜单抗原液及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7045314B2 (en) * | 2000-04-04 | 2006-05-16 | Baxter International Inc. | Method for the production of bacterial toxins |
| RU2011137030A (ru) * | 2009-03-11 | 2013-04-20 | УАЙТ ЭлЭлСи | Способы очистки малых модулярных иммунофармацевтических белков |
| AU2012328880B2 (en) * | 2011-10-24 | 2017-02-23 | Halozyme, Inc. | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| ES2895752T3 (es) * | 2014-01-03 | 2022-02-22 | Hoffmann La Roche | Anticuerpos biespecíficos anti-hapteno/anti-receptor de la barrera hematoencefálica, complejos de los mismos y su uso como lanzaderas a través de la barrera hematoencefálica |
| BR112016014969A2 (pt) * | 2014-01-15 | 2018-01-23 | Hoffmann La Roche | polipeptídeo, formulação farmacêutica e uso de um polipeptídeo |
| EP3054007A1 (en) * | 2015-02-09 | 2016-08-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step |
| JP6959912B2 (ja) * | 2015-09-23 | 2021-11-05 | ジェネンテック， インコーポレイテッド | 抗ｖｅｇｆ抗体の最適化変異体 |
| KR20250057128A (ko) * | 2015-12-30 | 2025-04-28 | 코디악 사이언시스 인코포레이티드 | 항체 및 이의 접합체 |
| US12071476B2 (en) * | 2018-03-02 | 2024-08-27 | Kodiak Sciences Inc. | IL-6 antibodies and fusion constructs and conjugates thereof |
| US20210254073A1 (en) * | 2020-02-04 | 2021-08-19 | Cornell University | Methods for capture and analysis of macromolecular complexes |
-
2023
- 2023-02-09 CA CA3251000A patent/CA3251000A1/en active Pending
- 2023-02-09 US US18/166,755 patent/US20230250133A1/en active Pending
- 2023-02-09 IL IL314472A patent/IL314472A/en unknown
- 2023-02-09 MX MX2024009755A patent/MX2024009755A/es unknown
- 2023-02-09 JP JP2024547315A patent/JP2025505696A/ja active Pending
- 2023-02-09 WO PCT/US2023/062322 patent/WO2023154822A2/en not_active Ceased
- 2023-02-09 EP EP23753671.9A patent/EP4476237A2/en active Pending
- 2023-02-09 AU AU2023217074A patent/AU2023217074A1/en active Pending
- 2023-02-09 KR KR1020247030267A patent/KR20240142564A/ko active Pending
- 2023-02-09 CN CN202380033420.7A patent/CN119032099A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240142564A (ko) | 2024-09-30 |
| CA3251000A1 (en) | 2023-08-17 |
| WO2023154822A3 (en) | 2023-09-21 |
| WO2023154822A2 (en) | 2023-08-17 |
| MX2024009755A (es) | 2024-08-20 |
| EP4476237A2 (en) | 2024-12-18 |
| WO2023154822A8 (en) | 2024-04-04 |
| AU2023217074A1 (en) | 2024-08-15 |
| US20230250133A1 (en) | 2023-08-10 |
| JP2025505696A (ja) | 2025-02-28 |
| CN119032099A (zh) | 2024-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB202001121D0 (en) | Process for there synthesis of buprenorphine | |
| NO20190144A1 (en) | A process for production of aluminium | |
| GB202202060D0 (en) | Product | |
| GB202403366D0 (en) | Product | |
| PT4172136T (pt) | Método de purificação de metanol bruto | |
| GB202214771D0 (en) | Oral product | |
| GB202214803D0 (en) | Oral product | |
| GB202214775D0 (en) | Oral product | |
| IL326885A (en) | Risdiplam purification process | |
| GB202105882D0 (en) | A synthesis method of saxagliptin intermediate | |
| HK40100763A (zh) | 截短侧耳素的纯化方法 | |
| GB202211033D0 (en) | Purification process | |
| CA3292747A1 (en) | A process for purification of ethofumesate | |
| ZA202105424B (en) | A method of producing a high protein product | |
| GB202306624D0 (en) | Pelletisation of a mineral product | |
| GB202511650D0 (en) | Product | |
| GB202511281D0 (en) | Product | |
| GB202510313D0 (en) | Product | |
| GB202508503D0 (en) | Product | |
| GB202507678D0 (en) | Product | |
| GB202506897D0 (en) | Product | |
| GB202416248D0 (en) | Purification process | |
| GB202418716D0 (en) | Product | |
| GB202417304D0 (en) | Product | |
| GB202416974D0 (en) | Product |